Craft

Solvonis Therapeutics

Stock Price

£0

2024-10-29

Market Capitalization

£3.1 M

2024-10-29

Solvonis Therapeutics Summary

Company Summary

Overview
Solvonis Therapeutics (formerly known as Graft Polymer UK) is a company that provides polymeric composite materials. It offers technologies such as power hybridization, hot ozonolysis, solid-state melt extrusion, flow-induced crystallization, etc.
Type
Public
Status
Active
Founded
2017
HQ
London, GB | view all locations
Website
https://solvonis.com/
Cybersecurity rating
Sectors

LocationsView all

1 location detected

  • London, England HQ

    United Kingdom

    21 Eccleston Pl

Solvonis Therapeutics Financials

Summary Financials

Net income (FY, 2025)
(£5.7M)
Cash (FY, 2025)
£1.7M
EBIT (FY, 2025)
(£4.7M)
Enterprise value
$1.4M

Footer menu